ArticlePloS one2025
Enhancing precision in lymphoma detection with novel deep transformer-based neural networks.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lymphoma appears as swollen lymph nodes and weakened immune-protective tissues, frequently resulting in tiredness and loss of weight. Improving the outlook of this malignancy includes using computer-assisted analysis of Positron Emission Tomography (PET) pictures, which identify changes in metabolism. This article presents an Automatic Pre-Segmentation Model (APSM) that uses the Swin Transformer (ST). The APSM accurately separates inputs by recognizing pixel differences caused by changes in metabolism in various tissues and lymph nodes. Training the Swin Transformer system for classification and identification happens simultaneously, focusing mainly on the lymph node area. The model effectively divides the Lymphoma area by examining differences in patterns between regional features and changes in pixels. This segmentation model combines transformer network training to simultaneously learn fractal variations and feature changes, helping to adjust the relationships between training and testing inputs. The segmentation model's effectiveness comes from its capability to stop training the matching transformer network when it identifies new deviations, alterations, or both. The proposed model achieved 12.68% higher segmentation accuracy, 13.38% improved precision, and reduced overhead, error, and segmentation time by 12.73%, 9.27%, and 10.23%, respectively, outperforming existing methods.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.